-
Gelomics Partners With Rousselot Biomedical to Create the World’s First, Ready-to-Use 3D Cell Culture Kits Based on X-PURE® GelMA
Irving, United States, 16th November 2022 / Sciad Newswire / Darling Ingredients’ Health Brand, Rousselot, the global leader in collagen-based solutions, and Gelomics, the world-leading provider of fully integrated 3D cell, organoid and tissue culture technologies, have entered into a cobranding partnership. Rousselot Biomedical will supply Gelomics with its X-Pure GelMA (gelatin methacryloyl), a photo cross-linkable extracellular matrix, for use…
-
Domainex expands Executive and Management Teams to support ongoing growth
Cambridge, UK, 15th November 2022 / Sciad Newswire / Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to announce that it has made a number of strategic internal promotions to strengthen its Executive and Management teams. This expansion marks a period of ongoing growth for Domainex, and the newly bolstered teams will be pivotal in driving…
-
BRIM Biotechnology receives FDA agreement on Phase 3 clinical trial design for BRM421, BRIM’s lead candidate for Dry Eye Disease, at End of Phase 2 Meeting
Taipei, Taiwan, 1st November 2022 / Sciad Newswire / BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885) is pleased to announce that it has received agreement from the US Food and Drug Administration (FDA) on the Phase 3 clinical trial design for its lead candidate for Dry Eye Disease (DED), BRM421, at the End of Phase 2 Meeting. BRIM will…
-
New NoriZite™ Nasal Spray launches in the UK
Award-winning innovation from Birmingham Biotech LTD and University of Birmingham is now available in the UK Birmingham, UK, 28th October 2022 / Sciad Newswire / Birmingham Biotech LTD, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces that NoriZite™ Nasal Spray, an easy-to-use nasal device designed to block and trap inhaled virus…
-
Sciad attends PPMA Total Show
By Jasmin Shearan, Account Manager Now that the Summer has drawn to a close, the Sciad team are keen to make the most of upcoming events in the science and engineering sectors. A few weeks ago I attended PPMA Total Show at the NEC, Birmingham. The event, which ran from 27th-29th of September, hosted 400…
-
Industry, academia, and policy makers set to discuss the future of healthcare at Pharma Integrates 2022
London, United Kingdom, 19th October 2022 / Sciad Newswire / Taking place on 17th November in London, Pharma Integrates is the must-attend event for leaders, strategists and innovators across pharma & healthcare looking to revolutionise modern medicine. An opportunity to make connections, discuss how to overcome market challenges and advance business goals. Our healthcare service is under pressure. With a…
-
Why low accuracy chemical dosing is money down the drain
By Adeel Hassan, Product Manager at Watson-Marlow Fluid Technology Solutions Companies in the process industries sector — from wastewater treatment providers to metal and mining or pulp and paper plants — face an extremely challenging operating climate in 2022 and beyond. Around the world, authorities are tightening the environmental regulations which govern chemical usage and…
-
Maternova Appoints Luna Mehrain, MD, MSc, as Chief Medical Officer
Providence, Rhode Island, 12th October, 2022 / Sciad Newswire / Maternova, Inc., accelerating advances in maternal and infant health through innovative, accessible solutions, today announced the appointment of Luna M. Mehrain, MD, MSc, as Chief Medical Officer. Dr. Mehrain, an accomplished Obstetrician/Gynecologist and strategic leader in reproductive, maternal and neonatal health, will assess the efficacy, safety and usability of diagnostics…
-
Watson-Marlow introduces KROHNE flowmeter to safeguard accuracy of fluid flow
Falmouth, UK, 11th October 2022 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS) today announces the company now offers the KROHNE FLEXMAG 4050 C ® electromagnetic flowmeter for biopharmaceutical customers. As a highly accurate and reliable flow measuring system that seamlessly integrates with other WMFTS products, it reinforces the company’s position as a provider of total-solution packages for customers utilising fluid path processes. Superior…
-
Amphista Therapeutics partners with Domainex to advance portfolio of drug discovery projects targeting protein degradation
Cambridge, United Kingdom, 6th October 2022 / Sciad Newswire / Amphista Therapeutics Ltd., a global leader in the discovery and development of next generation targeted protein degradation (TPD) therapeutics and recently named Fierce Biotech, Fierce 15 winner for 2022, has selected Domainex Ltd as one of its trusted partners to provide integrated drug discovery services to support its research programmes….